Security key
74907L300
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)
CUSIP: 74907L300
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
- Shares outstanding
- 9,352,472
- Total 13F shares
- 401,522
- Share change
- -1,144,932
- Total reported value
- $90,191
- Price per share
- $0.22
- Number of holders
- 9
- Value change
- -$858,956
- Number of buys
- 6
- Number of sells
- 9
Report period
Q1 2025
Institutions
9
Top holders
9
QNRX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Quoin Pharmaceuticals, Ltd. SEC filings
Quoin Pharmaceuticals, Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74907L300
Recent filing periods:
Top shareholders of QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
5%
|
1,081,183
|
$7,049,313 | $0 | 31 Mar 2025 | |
| Denise P. Carter |
13D/G
|
Denise Carter |
4.9%
|
939,238
|
$244,202 | +$82,374 | 27 Jan 2025 | |
| Michael Myers |
13D/G
|
— |
4.9%
|
939,230
|
$244,200 | +$82,331 | 27 Jan 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
3%
|
282,249
|
$183,659 | — | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.9%
|
275,000
|
$178,942 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
133,122
|
$86,622 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.86%
|
80,712
|
$52,519 | — | 31 Dec 2024 | |
| Apollon Wealth Management, LLC |
13F
|
Company |
0.86%
|
80,025
|
$52,072 | — | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.56%
|
52,526
|
$34,179 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.33%
|
31,047
|
$20,202 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.3%
|
27,714
|
$18,000 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.27%
|
25,119
|
$16,345 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.26%
|
24,126
|
$15,702 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
4,773
|
$3,107 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
24
|
$16 | — | 31 Dec 2024 | |
| Raiffeisen Bank International AG |
13F
|
Company |
0%
|
17
|
$11 | — | 31 Dec 2024 | |
| Gordon Dunn |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
734,513
mixed-class rows
|
$67,985 | — | 23 Dec 2024 |
Institutional Holders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) as of Q1 2025
As of 31 Mar 2025,
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
401,522 shares.
The largest 9 holders included
UBS Group AG, Apollon Wealth Management, LLC, RHUMBLINE ADVISERS, RAYMOND JAMES FINANCIAL INC, Lido Advisors, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, JPMORGAN CHASE & CO, and Raiffeisen Bank International AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
14
Q1 2025 holders
9
Holder diff
-5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.